In addition, non-tumor PD-L1 expression was shown in CD68+ tumor-associated macrophages in all eight patients, whereas in only one responder with MSI-H, less than 5% of PD-L1 was observed on tumor cells. This evidence concerns the gene CD68 and neoplasm.